HUMAN TRANSFORMING GROWTH-FACTOR TYPE-BETA-2 - PRODUCTION BY A PROSTATIC ADENOCARCINOMA CELL-LINE, PURIFICATION, AND INITIAL CHARACTERIZATION
HUMAN TRANSFORMING GROWTH-FACTOR TYPE-BETA-2 - PRODUCTION BY A PROSTATIC ADENOCARCINOMA CELL-LINE, PURIFICATION, AND INITIAL CHARACTERIZATION
复制标题
DOI:
10.1021/bi00383a002
复制
发表时间:
1987-05-05
期刊:
影响因子:
2.9
通讯作者:
MARQUARDT, H
中科院分区:
文献类型:
--
作者:
IKEDA, T;LIOUBIN, MN;MARQUARDT, H
Human type .beta.2 transforming growth factor (hTGF-.beta.2) was purified from tamoxifen-supplemented, serum-free medium conditioned by the human prostatic adenocarcinoma cell line PC-3. The purification of hTGF-.beta.2 was monitored in a growth inhibition assay and was achieved by batch purification on methylsilyl-controlled pore glass, followed by gel permeation chromatography and reversed-phase high-performance liquid chromatography. The overall recovery of hTGF-.beta.2 was 75% of the initial activity and yielded 22 .mu.g of hTGF-.beta.2/L of conditioned medium. The concentration of hTGF-.beta.2 required for half-maximal inhibition of Mv 1 Lu mink lung epithelial cells (CCl-64) was approximately 5 pM when assayed in the presence of 10% fetal bovine serum. The purified hTGF-.beta.2 has a molecular weight of 24,000 when analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and consists of two disulfide-linked, apparently identical polypeptide chains, with a molecular weight of 13,000. The amino-terminal sequence of hTGF-.beta.2 was determined. Alignment of the amino acid sequences of hTGF-.beta.2 and hTGF-.beta. reveals statistically significant sequence homology. On the basis of the extensive amino acid sequence homology, we propose the term TGF-.beta.2 for this newly isolated polypeptide. The reported results suggest that TGF-.beta. (TGF-.beta.1) and TGF-.beta.2 may have evolved from a common progenitor.